The closing price of Applied Therapeutics Inc (NASDAQ: APLT) was $5.78 for the day, down -2.36% from the previous closing price of $5.92. In other words, the price has decreased by -$0.14 from its previous closing price. On the day, 514125 shares were traded.
Ratios:
Our analysis of APLT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.80 and its Current Ratio is at 0.80.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, RBC Capital Mkts on March 26, 2024, initiated with a Outperform rating and assigned the stock a target price of $12.
On February 22, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $12.
Barclays Downgraded its Overweight to Equal Weight on January 04, 2022, whereas the target price for the stock was revised from $44 to $7.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 14 ’24 when Shendelman Shoshana sold 318,573 shares for $5.39 per share. The transaction valued at 1,717,108 led to the insider holds 3,817,814 shares of the business.
Perfetti Riccardo sold 110,804 shares of APLT for $597,234 on Mar 14 ’24. The Chief Medical Officer now owns 1,031,537 shares after completing the transaction at $5.39 per share. On Mar 14 ’24, another insider, Hansard Adam, who serves as the Chief Commercial Officer of the company, sold 48,871 shares for $5.39 each. As a result, the insider received 263,415 and left with 732,919 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, APLT now has a Market Capitalization of 612.03M and an Enterprise Value of 562.90M. For the stock, the TTM Price-to-Sale (P/S) ratio is 57.42. Its current Enterprise Value per Revenue stands at 56.33 whereas that against EBITDA is -8.77.
Stock Price History:
Over the past 52 weeks, APLT has reached a high of $9.39, while it has fallen to a 52-week low of $0.76. The 50-Day Moving Average of the stock is 5.22, while the 200-Day Moving Average is calculated to be 2.88.
Shares Statistics:
APLT traded an average of 2.14M shares per day over the past three months and 1.11M shares per day over the past ten days. A total of 84.87M shares are outstanding, with a floating share count of 74.23M. Insiders hold about 29.89% of the company’s shares, while institutions hold 56.10% stake in the company. Shares short for APLT as of Mar 15, 2024 were 3.79M with a Short Ratio of 1.77, compared to 3.87M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 3.58% and a Short% of Float of 4.06%.
Earnings Estimates
The firm’s stock currently is rated by 3 analysts. On average, analysts expect EPS of -$0.14 for the current quarter, with a high estimate of -$0.07 and a low estimate of -$0.18, while EPS last year was -$0.18. The consensus estimate for the next quarter is -$0.17, with high estimates of -$0.15 and low estimates of -$0.2.
Analysts are recommending an EPS of between -$0.53 and -$0.82 for the fiscal current year, implying an average EPS of -$0.72. EPS for the following year is -$0.39, with 4 analysts recommending between -$0.04 and -$0.7.
Revenue Estimates
A total of 3 analysts have provided revenue estimates for APLT’s current fiscal year. The highest revenue estimate was $17.2M, while the lowest revenue estimate was $1.76M, resulting in an average revenue estimate of $7.73M. In the same quarter a year ago, actual revenue was $9.99M, down -22.60% from the average estimate. Based on 4 analysts’ estimates, the company’s revenue will be $71.99M in the next fiscal year. The high estimate is $144.58M and the low estimate is $11.84M. The average revenue growth estimate for next year is up 831.30% from the average revenue estimate for this year.
